Search

Sumesh Kaushal

Examiner (ID: 12825)

Most Active Art Unit
1633
Art Unit(s)
1636, OPIM, OPA, 1633
Total Applications
513
Issued Applications
223
Pending Applications
79
Abandoned Applications
211

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6978530 [patent_doc_number] => 20050288248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use' [patent_app_type] => utility [patent_app_number] => 11/212439 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14133 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288248.pdf [firstpage_image] =>[orig_patent_app_number] => 11212439 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/212439
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use Aug 25, 2005 Issued
Array ( [id] => 5894880 [patent_doc_number] => 20060003419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use' [patent_app_type] => utility [patent_app_number] => 11/213087 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14113 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003419.pdf [firstpage_image] =>[orig_patent_app_number] => 11213087 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/213087
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use Aug 25, 2005 Issued
Array ( [id] => 5894879 [patent_doc_number] => 20060003418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use' [patent_app_type] => utility [patent_app_number] => 11/213083 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14109 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003418.pdf [firstpage_image] =>[orig_patent_app_number] => 11213083 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/213083
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use Aug 25, 2005 Abandoned
Array ( [id] => 5894878 [patent_doc_number] => 20060003417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use' [patent_app_type] => utility [patent_app_number] => 11/213026 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14110 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003417.pdf [firstpage_image] =>[orig_patent_app_number] => 11213026 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/213026
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use Aug 25, 2005 Issued
Array ( [id] => 356279 [patent_doc_number] => 07488715 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-10 [patent_title] => 'Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use' [patent_app_type] => utility [patent_app_number] => 11/213023 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14158 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/488/07488715.pdf [firstpage_image] =>[orig_patent_app_number] => 11213023 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/213023
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use Aug 25, 2005 Issued
Array ( [id] => 422031 [patent_doc_number] => 07273963 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-25 [patent_title] => 'Malarial animal model having a chimeric human liver' [patent_app_type] => utility [patent_app_number] => 11/207176 [patent_app_country] => US [patent_app_date] => 2005-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15083 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/273/07273963.pdf [firstpage_image] =>[orig_patent_app_number] => 11207176 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/207176
Malarial animal model having a chimeric human liver Aug 16, 2005 Issued
Array ( [id] => 5517083 [patent_doc_number] => 20090217390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Non-human animal sarcoma model' [patent_app_type] => utility [patent_app_number] => 11/919487 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6580 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20090217390.pdf [firstpage_image] =>[orig_patent_app_number] => 11919487 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/919487
Non-human animal sarcoma model Apr 28, 2005 Abandoned
Array ( [id] => 6931730 [patent_doc_number] => 20050282765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Enzyme having S-adenosyl-L-homocysteine hydrolase (AHCY) type activity' [patent_app_type] => utility [patent_app_number] => 11/110748 [patent_app_country] => US [patent_app_date] => 2005-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5456 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282765.pdf [firstpage_image] =>[orig_patent_app_number] => 11110748 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/110748
Enzyme having S-adenosyl-L-homocysteine hydrolase (AHCY) type activity Apr 20, 2005 Abandoned
Array ( [id] => 7216476 [patent_doc_number] => 20050260165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'HS-40 enhancer-containing vector' [patent_app_type] => utility [patent_app_number] => 11/103355 [patent_app_country] => US [patent_app_date] => 2005-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3583 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260165.pdf [firstpage_image] =>[orig_patent_app_number] => 11103355 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/103355
HS-40 enhancer-containing vector Apr 10, 2005 Abandoned
Array ( [id] => 7004652 [patent_doc_number] => 20050169965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Compounds with improved cartilage-inducing and/or bone-inducing activity' [patent_app_type] => utility [patent_app_number] => 11/080494 [patent_app_country] => US [patent_app_date] => 2005-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5970 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20050169965.pdf [firstpage_image] =>[orig_patent_app_number] => 11080494 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/080494
Compounds with improved cartilage-inducing and/or bone-inducing activity Mar 15, 2005 Issued
Array ( [id] => 809886 [patent_doc_number] => 07416859 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-26 [patent_title] => 'Rhodococcus cloning and expression vectors' [patent_app_type] => utility [patent_app_number] => 11/069691 [patent_app_country] => US [patent_app_date] => 2005-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18167 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/416/07416859.pdf [firstpage_image] =>[orig_patent_app_number] => 11069691 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/069691
Rhodococcus cloning and expression vectors Feb 28, 2005 Issued
Array ( [id] => 7185205 [patent_doc_number] => 20050191744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Method for differentiating primate embryonic stem cell into vascular cell' [patent_app_type] => utility [patent_app_number] => 11/063584 [patent_app_country] => US [patent_app_date] => 2005-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9732 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191744.pdf [firstpage_image] =>[orig_patent_app_number] => 11063584 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/063584
Method for differentiating primate embryonic stem cell into vascular cell Feb 23, 2005 Issued
Array ( [id] => 5678345 [patent_doc_number] => 20060183701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Methods and compositions for determining non-specific cytotoxicity of a transfection agent' [patent_app_type] => utility [patent_app_number] => 11/059209 [patent_app_country] => US [patent_app_date] => 2005-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17808 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183701.pdf [firstpage_image] =>[orig_patent_app_number] => 11059209 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/059209
Methods and compositions for determining non-specific cytotoxicity of a transfection agent Feb 14, 2005 Abandoned
Array ( [id] => 5769433 [patent_doc_number] => 20050265978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Muscle-derived cells (MDCs) for treating muscle- or bone-related injury or dysfunction' [patent_app_type] => utility [patent_app_number] => 11/040900 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 33312 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20050265978.pdf [firstpage_image] =>[orig_patent_app_number] => 11040900 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/040900
Muscle-derived cells (MDCs) for treating muscle- or bone-related injury or dysfunction Jan 20, 2005 Issued
Array ( [id] => 123663 [patent_doc_number] => 07705197 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-27 [patent_title] => 'Embryo development and survival' [patent_app_type] => utility [patent_app_number] => 11/039662 [patent_app_country] => US [patent_app_date] => 2005-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6299 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/705/07705197.pdf [firstpage_image] =>[orig_patent_app_number] => 11039662 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/039662
Embryo development and survival Jan 18, 2005 Issued
Array ( [id] => 8386412 [patent_doc_number] => 08263821 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Non-invasive real-time in vivo bioluminescence imaging of local CaÂ2+ dynamics in living organisms' [patent_app_type] => utility [patent_app_number] => 11/032236 [patent_app_country] => US [patent_app_date] => 2005-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 30 [patent_no_of_words] => 19013 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11032236 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/032236
Non-invasive real-time in vivo bioluminescence imaging of local CaÂ2+ dynamics in living organisms Jan 10, 2005 Issued
Array ( [id] => 7977235 [patent_doc_number] => 08071364 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Gene therapy using transposon-based vectors' [patent_app_type] => utility [patent_app_number] => 10/583812 [patent_app_country] => US [patent_app_date] => 2004-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 33281 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071364.pdf [firstpage_image] =>[orig_patent_app_number] => 10583812 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/583812
Gene therapy using transposon-based vectors Dec 23, 2004 Issued
Array ( [id] => 6968874 [patent_doc_number] => 20050235367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Regulatory sequences capable of conferring expression of a heterologous DNA sequence in endothelial cells and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/015329 [patent_app_country] => US [patent_app_date] => 2004-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 18985 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20050235367.pdf [firstpage_image] =>[orig_patent_app_number] => 11015329 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/015329
Regulatory sequences capable of conferring expression of a heterologous DNA sequence in endothelial cells and uses thereof Dec 16, 2004 Abandoned
Array ( [id] => 7136619 [patent_doc_number] => 20050181395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Systems for tightly regulated gene expression' [patent_app_type] => utility [patent_app_number] => 11/010599 [patent_app_country] => US [patent_app_date] => 2004-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 8741 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20050181395.pdf [firstpage_image] =>[orig_patent_app_number] => 11010599 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/010599
Systems for tightly regulated gene expression Dec 12, 2004 Abandoned
Array ( [id] => 4684288 [patent_doc_number] => 20080250514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Expression Systems Using Mammalian Beta-Actin Promoter' [patent_app_type] => utility [patent_app_number] => 10/581183 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12411 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20080250514.pdf [firstpage_image] =>[orig_patent_app_number] => 10581183 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/581183
Expression systems using mammalian beta-actin promoter Dec 2, 2004 Issued
Menu